HPR190 Evaluating the Impact of the Entry of IVD-R in the Biopharmaceutical Industry, With a Focus on Evidence Requirements and Time to Launch

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1319
https://www.valueinhealthjournal.com/article/S1098-3015(22)03524-0/fulltext
Title : HPR190 Evaluating the Impact of the Entry of IVD-R in the Biopharmaceutical Industry, With a Focus on Evidence Requirements and Time to Launch
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03524-0&doi=10.1016/j.jval.2022.09.1319
First page :
Section Title :
Open access? : No
Section Order : 10862
Categories :
Tags :
Regions :
ViH Article Tags :